Literature DB >> 25075080

Surgical outcomes of anatomical resection for solitary recurrent hepatocellular carcinoma.

Yo-Ichi Yamashita1, Daisuke Imai2, Yuki Bekki2, Kazuki Takeishi3, Eiji Tsujita3, Toru Ikegami4, Tomoharu Yoshizumi2, Tetsuo Ikeda2, Ken Shirabe2, Teruyoshi Ishida3, Yoshihiko Maehara2.   

Abstract

BACKGROUND: For eradicating portal venous tumor extension and intrahepatic metastasis in hepatocellular carcinoma (HCC), anatomical resection is, in theory, preferable. PATIENTS AND METHODS: We carried-out a retrospective cohort study in 110 patients who underwent curative hepatic resection (anatomical resection; n=20, and limited resection; n=90) for solitary recurrent HCC from 1990-2010.
RESULTS: No significant difference was found in short-term surgical results such as mortality, morbidity, and duration of hospital stay between the two groups. Anatomical resection did not influence overall and disease-free survival for all patients with a solitary recurrent HCC. In patients with cancer spread, such as pathological vascular invasion and intrahepatic metastasis (n=61), or with des-γ-carboxy prothrombin (DCP) ≥ 100 mAU/ml (n=73), the disease-free survival rate in the anatomical-resection group was significantly better than that in the limited-resection group (p=0.0452 and p=0.0345, respectively).
CONCLUSION: Anatomical resection should be recommended only for HCC suspected of exhibiting cancer spread as reflected by DCP ≥ 100 mAU/ml in patients with solitary recurrent HCC. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Recurrent hepatocellular carcinoma; anatomical resection; cancer spread; disease-free survival; overall survival; prognostic factors

Mesh:

Substances:

Year:  2014        PMID: 25075080

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Downregulation of RIP140 in hepatocellular carcinoma promoted the growth and migration of the cancer cells.

Authors:  Dexiang Zhang; Yueqi Wang; Yuedi Dai; Jiwen Wang; Tao Suo; Hongtao Pan; Han Liu; Sheng Shen; Houbao Liu
Journal:  Tumour Biol       Date:  2014-11-13

2.  Clinicopathological Characteristics of Hepatocellular Carcinoma with Microscopic Portal Venous Invasion and the Role of Anatomical Liver Resection in These Cases.

Authors:  Shingo Shimada; Toshiya Kamiyama; Hideki Yokoo; Tatsuya Orimo; Kenji Wakayama; Takahiro Einama; Tatsuhiko Kakisaka; Hirofumi Kamachi; Akinobu Taketomi
Journal:  World J Surg       Date:  2017-08       Impact factor: 3.352

3.  Treatment and outcomes of recurrent hepatocellular carcinomas.

Authors:  Gaëtan-Romain Joliat; Pierre Allemann; Ismail Labgaa; Nicolas Demartines; Nermin Halkic
Journal:  Langenbecks Arch Surg       Date:  2017-05-11       Impact factor: 3.445

4.  Pre-treatment double- or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma.

Authors:  Hidetoshi Nitta; Shigeki Nakagawa; Takayoshi Kaida; Kota Arima; Takaaki Higashi; Katsunobu Taki; Hirohisa Okabe; Hiromitsu Hayashi; Daisuke Hashimoto; Akira Chikamoto; Takatoshi Ishiko; Toru Beppu; Hideo Baba
Journal:  Surg Today       Date:  2016-08-22       Impact factor: 2.549

5.  Elongator promotes the migration and invasion of hepatocellular carcinoma cell by the phosphorylation of AKT.

Authors:  Yi Xu; Wei Zhou; Yuan Ji; Jian Shen; Xiaxia Zhu; Huijun Yu; Jingchun Guo; Zhi Pang; Wenxiang Wei
Journal:  Int J Biol Sci       Date:  2018-04-05       Impact factor: 6.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.